Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

被引:972
作者
Mathers, Bradley M. [1 ,2 ]
Degenhardt, Louisa [1 ,2 ]
Phillips, Benjamin [1 ]
Wiessing, Lucas [3 ]
Hickman, Matthew [4 ]
Strathdee, Steffanie A. [5 ]
Wodak, Alex [1 ,2 ,6 ]
Panda, Samiran [7 ,8 ]
Tyndall, Mark [9 ]
Toufik, Abdalla [10 ]
Mattick, Richard P. [1 ,2 ]
机构
[1] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Secretariat Reference Grp UN HIV & Injecting Drug, Sydney, NSW 2052, Australia
[3] European Monitoring Ctr Drugs & Drug Addict, Crime & Markets Unit, Lisbon, Portugal
[4] Univ Bristol, Bristol, Avon, England
[5] Univ Calif San Diego, Div Int Hlth & Cross Cultural Med, San Diego, CA 92103 USA
[6] St Vincents Hosp, Alcohol & Drug Serv, Sydney, NSW 2010, Australia
[7] Indian Council Med Res, Natl Inst Cholera & Enter Dis, W Bengal, India
[8] Soc Posit Atmosphere & Related Support HIV AIDS S, W Bengal, India
[9] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada
[10] French Monitoring Ctr Drugs & Drug Addict, Emerging Trends Dept, Paris, France
基金
澳大利亚国家健康与医学研究理事会;
关键词
D O I
10.1016/S0140-6736(08)61311-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. Methods We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. Findings Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total Population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11 . 0-21.2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%,16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3 . 0 million (range 0 . 8-6.6 million) people who inject drugs might be HIV positive. Interpretation The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions. Funding UN Office on Drugs and Crime; Australian National Drug and Alcohol Research Centre, University of New South Wales.
引用
收藏
页码:1733 / 1745
页数:13
相关论文
共 22 条
[1]   Global overview of injecting drug use and HIV infection among injecting drug users [J].
Aceijas, C ;
Stimson, GV ;
Hickman, M ;
Rhodes, T .
AIDS, 2004, 18 (17) :2295-2303
[2]   Oslo Ministerial Declaration - global health: a pressing foreign policy issue of our time [J].
Amorim, Celso ;
Douste-Blazy, Philippe ;
Wirayuda, Hasan ;
Store, Jonas Gahr ;
Gadio, Cheikh Tidiane ;
Dlamini-Zuma, Nkosazana ;
Pibulsonggram, Nitya .
LANCET, 2007, 369 (9570) :1373-1378
[3]  
[Anonymous], EPIDEMIOLOGY DRUG AB
[4]  
[Anonymous], COMP QUANTIFICATION
[5]  
BALL AL, 1998, PUBLIC HLTH REPORTS, V113, P12
[6]  
BORSCHEVSKAYA V, 2006, COUNTRY REPORT RUSSI
[7]   The spread and effect of HIV-1 infection in sub-Saharan Africa [J].
Buvé, A ;
Bishikwabo-Nsarhaza, K ;
Mutangadura, G .
LANCET, 2002, 359 (9322) :2011-2017
[8]  
CALABRIA B, 2008, 293 NDARC
[9]  
*EMCDAA, 2007, 2007 ANN REP STAT DR
[10]   Selected major risk factors and global and regional burden of disease [J].
Ezzati, M ;
Lopez, AD ;
Rodgers, A ;
Vander Hoorn, S ;
Murray, CJL .
LANCET, 2002, 360 (9343) :1347-1360